Itau Unibanco Holding S.A. Catalent, Inc. Transaction History

Itau Unibanco Holding S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$53.58 - $57.02 $17,627 - $18,759	329 New	329 $18,000
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $8,302 - $12,015	-258 Reduced 33.2%	519 $23,000
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $88 - $100	-2 Reduced 0.26%	777 $35,000
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $1,306 - $2,757	-41 Reduced 5.0%	779 $33,000
Q4 2022 Feb 09, 2023	SELL	$41.39 - $81.0 $95,776 - $187,434	-2,314 Reduced 73.84%	820 $36,000
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $178,801 - $279,470	2,471 Added 372.7%	3,134 $227,000
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $11,423 - $14,940	-131 Reduced 16.5%	663 $71,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $847 - $1,120	9 Added 1.15%	794 $88,000
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $36,229 - $42,138	303 Added 62.86%	785 $101,000
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $1,310 - $1,708	12 Added 2.55%	482 $64,000
Q2 2021 Aug 17, 2021	BUY	$100.34 - $115.69 $47,159 - $54,374	470 New	470 $51,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.